Combined PET and microdialysis for in vivo assessment of intracellular drug pharmacokinetics in humans

Journal of Nuclear Medicine

Volumn 46, Issue 11, 2005, Pages 1835-1841

  Langer, Oliver ^a   Karch, Rudolf ^a   Müller, Ulrich ^a   Dobrozemsky, Georg ^a   Abrahim, Aiman ^a   Zeitlinger, Markus ^a   Lackner, Edith ^a   Joukhadar, Christian ^a   Dudczak, Robert ^a   Kletter, Kurt ^a   Müller, Markus ^a   Brunner, Martin ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Ciprofloxacin; Humans; Intracellular concentration; Microdialysis; PET

Indexed keywords

CIPROFLOXACIN; FLUORINE 18; FLUORINE CIPROFLOXACIN F 18; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; FLUORINE;

ADULT; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; DRUG DISTRIBUTION; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; ISOTOPE LABELING; MICRODIALYSIS; NORMAL HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SKELETAL MUSCLE; ALGORITHM; ANTIBODY SPECIFICITY; BIOLOGICAL MODEL; CLINICAL TRIAL; COMPUTER ASSISTED DIAGNOSIS; COMPUTER SIMULATION; INTRACELLULAR FLUID; KINETICS; MALE; METABOLIC CLEARANCE RATE; METABOLISM; METHODOLOGY; SCINTISCANNING; TISSUE DISTRIBUTION;

ADULT; ALGORITHMS; CIPROFLOXACIN; COMPUTER SIMULATION; FLUORINE RADIOISOTOPES; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; INTRACELLULAR FLUID; KINETICS; MALE; METABOLIC CLEARANCE RATE; MICRODIALYSIS; MODELS, BIOLOGICAL; MUSCLE, SKELETAL; ORGAN SPECIFICITY; POSITRON-EMISSION TOMOGRAPHY; TISSUE DISTRIBUTION;

EID: 33644820018     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Müller M, de la Peña A, Derendorf H. Issues in pharmacokinetics and pharmacodynamics of anti-infective agents. II. Tissue distribution. Antimicrob Agents Chemother. 2004;48:1441-1453.
2. Fischman AJ, Alpert NM, Rubin RH. Pharmacokinetic imaging, a noninvasive method for determining drug distribution and action. Clin Pharmacokinet. 2002; 41:581-602.
3. Müller M. Science, medicine, and the future: microdialysis. Br Med J. 2002;324: 588-591.
4. Langer O, Müller M. Methods to assess tissue-specific distribution and metabolism of drugs. Curr Drug Metab. 2004;5:463-481.
5. Fischman AJ, Alpert NM, Babich JW, Rubin RH. The role of positron emission tomography in pharmacokinetic analysis. Drug Metab Rev. 1997;29:923-956.
6. Müller M. Microdialysis in clinical drug delivery studies. Adv Drug Deliv Rev. 2000;45:255-269.
7. Langer O, Mitterhauser M, Brunner M, et al. Synthesis of fluorine-18-labeled ciprofloxacin for PET studies in humans. Nucl Med Biol. 2003;30:285-291.
8. 18F]Ciprofloxacin, a new positron emission tomography tracer for noninvasive assessment of the tissue distribution and pharmacokinetics of ciprofloxacin in humans. Antimicrob Agents Chemother. 2004;48:3850-3857.
9. 18F]ciprofloxacin for the imaging of bacterial infections with PET. Eur J Nucl Med Mol Imaging. 2005;32:143-150.
10. Ståhle L, Arner P, Ungerstedt U. Drug distribution studies with microdialysis. III. Extracellular concentration of caffeine in adipose tissue in man. Life Sci. 1991; 49:1853-1858.
11. Müller M, Haag O, Burgdorff T, et al. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans. Antimicrob Agents Chemother. 1996;40:2703-2709.
12. Araki H, Ogake N, Tsuneda R, et al. Muscle distribution of antimicrobial agents after a single intravenous administration to rats. Drug Metab Pharmacokinet. 2002;17:237-244.
13. Nilius AM, Shen LL, Hensey-Rudloff D, et al. In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinolone. Antimicrob Agents Chemother. 2003;47:3260-3269.
14. Tsuji A, Nishide K, Minami H, Nakashima E, Terasaki T, Yamana T. Physiologically based pharmacokinetic model for cefazolin in rabbits and its preliminary extrapolation to man. Drug Metab Dispos. 1985;13:729-739.
15. Neckel U, Joukhadar C, Frossard M, Jäger W, Müller M, Mayer BX. Simultaneous determination of levofloxacin and ciprofloxacin in microdialysates and plasma by high-performance liquid chromatography. Anal Chim Acta. 2002;463: 199-206.
16. Phelps ME, Huang SC, Hoffman EJ, Selin C, Sokoloff L, Kuhl DE. Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: validation of method. Ann Neurol. 1979;6:371-388.
17. 18F]FDG in skeletal muscle by PET: a four-compartment five-rate-constant model. Am J Physiol Endocrinol Metab. 2001;281:E524-E536.
18. Hoffken G, Lode H, Prinzing C, Borner K, Koeppe P. Pharmacokinetics of ciprofloxacin after oral and parenteral administration. Antimicrob Agents Chemother. 1985;27:375-379.
19. Müller M, Brunner M, Hollenstein U, et al. Penetration of ciprofloxacin into the interstitial space of inflamed foot lesions in non-insulin-dependent diabetes mellitus patients. Antimicrob Agents Chemother. 1999;43:2056-2058.
20. Brunner M, Hollenstein U, Delacher S, et al. Distribution and antimicrobial activity of ciprofloxacin in human soft tissues. Antimicrob Agents Chemother. 1999;43:1307-1309.
21. Brunner M, Stass H, Möller JG, et al. Target site concentrations of ciprofloxacin after single intravenous and oral doses. Antimicrob Agents Chemother. 2002;46: 3724-3730.
22. Tulkens PM. Intracellular distribution and activity of antibiotics. Eur J Clin Microbiol Infect Dis. 1991;10:100-106.
23. Pechere JC. Quinolones in intracellular infections. Drugs. 1993;45(suppl 3):29-36.
24. Maurin M, Raoult D. Intracellular organisms. Int J Antimicrob Agent. 1997;9: 61-70.
25. Seral C, Carryn S, Tulkens PM, Van Bambeke F. Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus. J Antimicrob Chemother. 2003;51:1167-1173.
26. Garraffo R, Jambou D, Chichmanian RM, Ravoire S, Lapalus P. In vitro and in vivo ciprofloxacin pharmacokinetics in human neutrophils. Antimicrob Agents Chemother. 1991;35:2215-2218.
27. Bounds SJ, Walters JD, Nakkulka RJ. Fluoroquinolone transport by human monocytes: characterization and comparison to other cells of myeloid lineage. Antimicrob Agents Chemother. 2000;44:2609-2614.
28. Walters JD, Zhang F, Nakkulka RJ. Mechanisms of fluoroquinolone transport by human neutrophils. Antimicrob Agents Chemother. 1999;43:2710-2715.
29. Mortimer PGS, Piddock LJV. A comparison of methods used for measuring the accumulation of quinolones by enterobacteriaceae, Pseudomonas aeruginosa and Staphylococcus aureus. J Antimicrob Chemother. 1991;28:639-653.